
Danaher Corporation DHR
€ 178.57
0.53%
Danaher Corporation Current Ratio | DHR
Current Ratio Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 5.19 | 1.47 | 1.43 | 0.97 | 1.27 | 1.75 | 2.01 | 1.8 | 1.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.19 | 0.97 | 1.93 |
Current Ratio anderer Aktien in der Diagnostik & Forschung
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 288.5 | 0.54 % | $ 14.3 B | ||
|
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | ||
|
DarioHealth Corp.
DRIO
|
4.85 | $ 7.24 | 3.72 % | $ 28.8 M | ||
|
Brainsway Ltd.
BWAY
|
2.37 | $ 14.15 | 1.61 % | $ 481 M | ||
|
Celcuity
CELC
|
1.27 | $ 95.7 | 0.44 % | $ 4.47 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
0.338 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.42 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 237.14 | 2.07 % | $ 26.3 B | ||
|
DexCom
DXCM
|
1.76 | $ 87.9 | 0.02 % | $ 34.3 B | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 | $ 164.85 | 0.78 % | $ 12.9 B | ||
|
Soleno Therapeutics
SLNO
|
4.96 | - | - | $ 2.69 B | ||
|
Psychemedics Corporation
PMD
|
2.61 | - | -1.84 % | $ 15.3 M | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Syneos Health
SYNH
|
1.74 | - | - | $ 4.46 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 326.89 | 0.29 % | $ 27.2 B | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
0.87 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
6.14 | - | -16.95 % | $ 1.54 M | ||
|
T2 Biosystems
TTOO
|
0.554 | - | -39.35 % | $ 313 K | ||
|
Anixa Biosciences
ANIX
|
7.55 | $ 3.07 | 0.66 % | $ 99.6 K | ||
|
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | ||
|
Meridian Bioscience
VIVO
|
2.42 | - | - | $ 1.49 B | ||
|
Quotient Limited
QTNT
|
0.574 | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
0.994 | $ 1 345.26 | 0.11 % | $ 27.7 B | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 3.18 | 1.57 % | $ 294 M | ||
|
ENDRA Life Sciences
NDRA
|
2.42 | $ 6.05 | 6.51 % | $ 4.76 M | ||
|
National Research Corporation
NRC
|
1.12 | $ 21.53 | 1.32 % | $ 482 M | ||
|
Renalytix AI plc
RNLX
|
0.504 | - | 5.66 % | $ 22.7 M | ||
|
Interpace Biosciences
IDXG
|
2.95 | $ 1.45 | 2.11 % | $ 6.41 M | ||
|
OPKO Health
OPK
|
2.91 | $ 1.64 | 1.86 % | $ 1.23 B | ||
|
Pacific Biosciences of California
PACB
|
1.01 | $ 1.35 | 3.85 % | $ 405 M | ||
|
IQVIA Holdings
IQV
|
1.28 | $ 267.77 | 2.95 % | $ 46 B | ||
|
Surmodics
SRDX
|
2.99 | - | - | $ 608 M | ||
|
Personalis
PSNL
|
4.58 | $ 17.2 | 2.2 % | $ 1.53 B | ||
|
Quidel Corporation
QDEL
|
3.39 | $ 13.97 | 0.29 % | $ 588 M |